Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome
- 3 February 2011
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (5), 452-458
- https://doi.org/10.1111/j.1600-0412.2010.01067.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trialJournal of Human Hypertension, 2008
- Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up studyEuropean Journal of Clinical Investigation, 2008
- Magnesium intake and risk of type 2 diabetes: a meta‐analysisJournal of Internal Medicine, 2007
- Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and PitfallsObstetrical & Gynecological Survey, 2004
- Polycystic Ovary SyndromeObstetrics & Gynecology, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome XMolecular Aspects of Medicine, 2003
- Divalent cations in women with PCOS: implications for cardiovascular diseaseGynecological Endocrinology, 2001
- Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The aric studyJournal of Clinical Epidemiology, 1995